Latest Progress in the Identification of Novel Synthetic Ligands for the Cannabinoid CB2 Receptor

ISSN: 1875-5607 (Online)
ISSN: 1389-5575 (Print)

Volume 17, 18 Issues, 2017

Download PDF Flyer

Mini-Reviews in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 21st of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.841
5 - Year: 2.963

Latest Progress in the Identification of Novel Synthetic Ligands for the Cannabinoid CB2 Receptor

Mini-Reviews in Medicinal Chemistry, 14(5): 426-443.

Author(s): Shuang Han, Jiong-Jiong Chen and Jian-Zhong Chen.

Affiliation: College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, P. R. China.


Cannabinoid receptors, belonging to the superfamily of G-protein coupled receptors, play a major role in pathophysiology of a wide range of disparate diseases. Cannabinoid CB2 receptor, which mainly locates in peripheral tissues, represents as a promising drug target for the treatment of pain, osteoporosis, liver disorders, and so on without serious CNS side effects. In the past decades, the identification and optimization of selective ligands for the CB2 receptor has been a major objective in drug discovery. In the present review, we describe recent advances in the development of novel chemotypes of the CB2 receptor selective ligands, and give a simple discussion for the corresponding structureactivity relationships of them.


Cannabinoid receptors, CB2, GPCRs, selective ligand, structure-activity relationship.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 5
First Page: 426
Last Page: 443
Page Count: 18
DOI: 10.2174/1389557514666140428105753
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science